These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6456623)

  • 1. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U; Merétey K; Falus A; Bozsóky S
    Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
    Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
    J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
    Crawhall JC
    Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes in solid tumours precipitable by 3.5% polyethylene glycol: analysis of some nonspecific components.
    Guidi L; Baroni R; Bartoloni C; Pellegrino M; Tricerri A; Marciano M; Barone C; Gambassi G
    Diagn Clin Immunol; 1988; 5(6):284-8. PubMed ID: 3219777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Vanes LA
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
    Weissmann G
    Bull NYU Hosp Jt Dis; 2009; 67(3):251-3. PubMed ID: 19852746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathologic mechanism in some ocular diseases].
    Rogoz S; Avramescu C; Siloşi I; Drackoulogona O; Badea P; State A
    Oftalmologia; 2002; 54(3):51-5. PubMed ID: 12723199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune interferon in the circulation of patients with autoimmune disease.
    Hooks JJ; Moutsopoulos HM; Geis SA; Stahl NI; Decker JL; Notkins AL
    N Engl J Med; 1979 Jul; 301(1):5-8. PubMed ID: 449915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
    Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
    Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
    Arroyave CM; Wilson MR; Tan EM
    J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.